Skip to main content
CRNX logo

CRNX · Crinetics Pharmaceuticals, Inc.

$83.90 +0.03 (+0.04%) At close · Jul 21
Market Cap
$8.85B
Shares
105.44M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-07-02 JEFF KNIGHT 47,420
2026-07-02 ROGERIO VIVALDI COELHO 6,000
2026-06-17 STEPHANIE OKEY 6,900
2026-05-04 JEFF KNIGHT 9,485
2026-04-14 JEFF KNIGHT 20,900
2026-04-13 JEFF KNIGHT 4,434
2026-04-08 JEFF KNIGHT 85,163
2026-03-18 DANA PIZZUTI 24,756
2026-03-16 Stephen Betz 26,525
2026-03-16 Richard Scott Struthers 45,013
2026-03-16 Jeff Knight 25,113
2026-03-12 ROGERIO VIVALDI COELHO 5,000
2026-03-03 STEPHANIE S OKEY 3,000
2026-03-02 Tobin Schilke 6,800
2026-02-02 DANA PIZZUTI 10,000
2026-01-05 ISABEL KALOFONOS 2,500
2026-01-02 DANA PIZZUTI 5,000
2025-12-01 DANA PIZZUTI 5,000
2025-11-03 DANA PIZZUTI 5,000
2025-10-01 DANA PIZZUTI 5,000
2025-09-26 Struthers Richard Scott 4,000
2025-09-26 MATTHEW K FUST 16,000
2025-09-02 DANA PIZZUTI 5,000
2025-08-22 DANA PIZZUTI 30,000
2025-08-20 DANA PIZZUTI 6,492
2025-06-12 STEPHEN BETZ 97,483
2025-02-03 DANA J PIZZUTI 5,000
2025-01-03 DANA J PIZZUTI 15,000
2024-12-02 Struthers Richard Scott 10,000
2024-10-03 DANA J PIZZUTI 14,375
2024-09-26 MARC WILSON 25,000
2024-09-10 Betz Stephen F. 1,035
2024-08-26 Betz Stephen F. 3,000
2024-08-12 Betz Stephen F. 3,000
2024-07-25 MARC WILSON 19,056
2024-07-25 Betz Stephen F. 3,000
2024-07-15 MARC WILSON 25,000
2024-07-15 JEFF KNIGHT 27,000
2024-07-10 Betz Stephen F. 3,000
2024-07-05 JAMES HASSARD 15,000
2024-07-03 DANA J PIZZUTI 14,375
2024-06-28 MARC WILSON 32,129
2024-06-25 Betz Stephen F. 3,000
2024-06-24 Pizzuti Dana 9,500
2024-06-21 JAMES HASSARD 15,000
2024-06-10 Betz Stephen F. 3,000
2024-05-28 Betz Stephen F. 3,000
2024-05-10 Betz Stephen F. 3,000
2024-05-08 Struthers Richard Scott 107,448
2024-04-15 DANA J PIZZUTI 14,375
Showing 1–50 of 77 filings
Key facts CIK 1658247 CUSIP 22663K107 13F (30d) 24 filings 23 filers Visit website Investor relations